Adenosine A3 receptor knockout (A3AR KO) mice and their wild-type (WT) counterparts were compared from the point of view of their abilities to survive exposures to lethal doses of γ-radiation belonging to the range of radiation doses inducing the bone marrow acute radiation syndrome. Parameters of cumulative 30-day survival (experiment using a midlethal radiation dose) or cumulative 11-day survival (experiment using an absolutely lethal radiation dose), and of mean survival time were evaluated. The values of A3AR KO mice always reflected their higher survival in comparison with WT ones, the P values being above the limit for statistical significance after the midlethal radiation dose and standing for statistical significance after the absolutely lethal radiation dose. This finding was considered surprising, taking into account the previously obtained findings on defects in numbers and functional properties of peripheral blood cells in A3AR KO mice. Therefore, previous hematological analyses of A3AR KO mice were supplemented in the present studies with determination of serum levels of the granulocyte colony-stimulating factor, erythropoietin, and thrombopoietin. Though distinct differences in these parameters were observed between A3AR KO and WT mice, none of them could explain the relatively high postirradiation survival of A3AR KO mice. Further studies on these mice comprising also those on other than hemopoietic tissues and organs can help to clarify their relative radioresistance.

Department of Molecular Cytology and Cytometry Institute of Biophysics v v i Academy of Sciences of the Czech Republic Královopolská 135 61265 Brno Czech Republic

Zobrazit více v PubMed

Abbracchio MP. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res. 1996;39:393–406. doi: 10.1002/(SICI)1098-2299(199611/12)39:3/4<393::AID-DDR21>3.0.CO;2-1. DOI

Neary JT, Burnstock G. Purinoceptors in the regulation of cell growth and differentiation. Drug Dev Res. 1996;39:407–412. doi: 10.1002/(SICI)1098-2299(199611/12)39:3/4<407::AID-DDR22>3.0.CO;2-X. DOI

Jacobson KA, Hoffman C, Cattabeni F, Abbracchio MP. Adenosine-induced cell death: evidence for receptor-mediated signalling. Apoptosis. 1999;4:197–211. doi: 10.1023/A:1009666707307. PubMed DOI

Schulte G, Fredholm BB. Signalling from adenosine receptor to nitrogen-activated protein kinases. Cell Signal. 2003;15:813–827. doi: 10.1016/S0898-6568(03)00058-5. PubMed DOI

Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol. 1995;35:581–606. doi: 10.1146/annurev.pa.35.040195.003053. PubMed DOI

Hofer M, Pospisil M, Weiterova L, Hoferova Z. The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules. 2011;16:675–685. doi: 10.3390/molecules16010675. PubMed DOI PMC

Hofer M, Pospíšil M, Hoferová Z, Komůrková D, Pápar P, Savvulidi F, Šefc L. The pharmacological activation of adenosine A1 and A3 receptors does not modulate the long- or short-term repopulating ability of hematopoietic stem and multipotent progenitor cells in mice. Purinergic Signal. 2013;9:207–214. doi: 10.1007/s11302-012-9340-5. PubMed DOI PMC

Fishman P, Bar-Yehuda S. Pharmacology and therapeutical applications of A3 receptor subtype. Curr Top Med Chem. 2003;3:463–469. doi: 10.2174/1568026033392147. PubMed DOI

Wu WP, Hao JX, Halldner-Henriksson L, Xu XJ, Jacobson MA, Wiesenfeld-Hallin Z, Fredholm BB. Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors. Neuroscience. 2002;14:523–527. doi: 10.1016/S0306-4522(02)00273-7. PubMed DOI

Fedorova IM, Jacobson MA, Basile A, Jacobson KA. Behavioral characterization of mice lacking the adenosine A3 receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol. 2003;23:431–447. doi: 10.1023/A:1023601007518. PubMed DOI PMC

Björklund O, Halldner-Henriksson L, Yang J, Eriksson TM, Jacobson MA, Daré E, Fredholm BB. Decreased behavioral activation following caffeine, amphetamine and darkness in A3 adenosine receptor knock-out mice. Physiol Behav. 2008;95:668–676. doi: 10.1016/j.physbeh.2008.09.018. PubMed DOI

Yang J, Wang Y, Garcia-Roves PM, Bjornholm M, Fredholm BB. Adenosine A3 receptors regulate heart rate, motor activity and body temperature. Acta Physiol. 2010;199:221–230. doi: 10.1111/j.1748-1716.2010.02091.x. PubMed DOI PMC

Shen H, Luo Y, Yu S-J, Wang Y. Enhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant mice. Neuroscience. 2011;194:170–180. doi: 10.1016/j.neuroscience.2011.08.013. PubMed DOI PMC

Hofer M, Pospíšil M, Dušek L, Hoferová Z, Weiterová L, Komůrková D. Erythropoiesis- and thrombopoiesis-characterizing parameters in adenosine A3 knock-out mice. Physiol Res. 2013;62:305–311. PubMed

Hofer M, Pospíšil M, Dušek L, Hoferová Z, Komůrková D. Evidence for compensatory mechanisms in the hematopoietic system of irradiated and non-irradiated mice lacking adenosine A3 receptors. Purinergic Signal. 2014;10:509–514. doi: 10.1007/s11302-014-9412-9. PubMed DOI PMC

Hofer M, Pospíšil M, Dušek L, Hoferová Z, Komůrková D (2014) Hematopoiesis in 5-fluorouracil-treated adenosine A3 receptor knock-out mice. Physiol Res, in press 2015 PubMed

Salvatore CA, Tilley SL, Latour AM, Fletcher DS, Koller BH, Jacobson MA. Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem. 2000;275:4429–4434. doi: 10.1074/jbc.275.6.4429. PubMed DOI

Bond VP, Fliedner TM, Archambeau JO. The radiation syndromes. In: Bond VP, Fliedner TM, Archambeau JO, editors. Mammalian radiation lethality. New York: Academic Press; 1965. pp. 101–114.

Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G. Adenosine acts as a chemoprotective agent by stimulating G-CSF production. A role for A1 and A3 adenosine receptors. J Cell Physiol. 2000;183:393–398. doi: 10.1002/(SICI)1097-4652(200006)183:3<393::AID-JCP12>3.0.CO;2-G. PubMed DOI

Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res. 2001;269:230–236. doi: 10.1006/excr.2001.5327. PubMed DOI

Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A, Cohn S, Fishman P. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Exp Hematol. 2002;30:1390–1398. doi: 10.1016/S0301-472X(02)00962-1. PubMed DOI

Fishman P, Bar-Yehuda S, Madi L, Cohn I. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs. 2002;13:437–443. doi: 10.1097/00001813-200206000-00001. PubMed DOI

Hofer M, Pospíšil M, Šefc L, Dušek L, Vacek A, Holá J, Hoferová Z, Štreitová D. Activation of adenosine A3 receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice. Int J Radiat Biol. 2010;86:649–656. doi: 10.3109/09553001003746075. PubMed DOI

Hofer M, Vacek A, Pospíšil M, Holá J, Štreitová D, Znojil V. Activation of adenosine A3 receptors potentiates stimulatory effects of IL-3, SCF, and GM-CSF on mouse granulocyte-macrophage hematopoietic progenitor cells. Physiol Res. 2009;58:247–252. PubMed

Štreitová D, Šefc L, Savvulidi F, Pospíšil M, Holá J, Hofer M. Adenosine A1, A2a, A2b, and A3 receptors in hematopoiesis: 1. Expression of receptor mRNA in four mouse hematopoietic precursor cells. Physiol Res. 2010;59:133–137. PubMed

Pospíšil M, Hofer M, Vacek A, Znojil V, Pipalová I. Effects of stable adenosine receptor agonists on bone marrow haematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol Res. 2004;53:549–556. PubMed

Bhanu NV, Aerbajinai W, Gantt NM, Jackson EK, Goh SH, Lee YT, Miller JL. Cl-IB-MECA inhibits human erythropoiesis. Br J Haematol. 2007;137:233–236. doi: 10.1111/j.1365-2141.2007.06540.x. PubMed DOI

Goodman JW, Smith LH. Erythrocyte life span in normal mice and in radiation bone marrow chimeras. Am J Physiol. 1961;200:764–770. PubMed